$200-235k
+ Annual performance-based bonus + Long-term incentive units (equity)
Platform personalising cancer testing
Open for applications
Platform personalising cancer testing
201-500 employees
Open for applications
$200-235k
+ Annual performance-based bonus + Long-term incentive units (equity)
201-500 employees
To transform the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response.